Showing results (251-260 of 322) with videos related to
Sort By:
Pageof 33
Bone Marrow Transplantation|February 1, 1997
No prevention of cytomegalovirus infection by anti-cytomegalovirus hyperimmune globulin in seronegative bone marrow transplant recipients. The Nordic BMT GroupT Ruutu, P Ljungman, L Brinch, et al.British Journal of Haematology|February 13, 2001
Stem cell transplantation for the treatment of Fanconi anaemia using a fludarabine-based cytoreductive regimen and T-cell-depleted related HLA-mismatched peripheral blood stem cell graftsF Boulad, A Gillio, T N Small, et al.Bone Marrow Transplantation|June 18, 1999
Nutritional status and growth after bone marrow transplantation (BMT) during childhood: EBMT Late-Effects Working Party retrospective data. European Group for Blood and Marrow TransplantationA Cohen, T Duell, G Socié, et al.Annals of Internal Medicine|February 1, 1997
Health and functional status of long-term survivors of bone marrow transplantation. EBMT Working Party on Late Effects and EULEP Study Group on Late Effects. European Group for Blood and Marrow TransplantationT Duell, M T van Lint, P Ljungman, et al.Bone Marrow Transplantation|January 2, 1997
Long-term survival in allogeneic bone marrow transplant recipients following acyclovir prophylaxis for CMV infection. The European Acyclovir for CMV Prophylaxis Study GroupH G Prentice, E Gluckman, R L Powles, et al.Bone Marrow Transplantation|January 6, 2004
Viridans streptococcal septicaemia in neutropenic patients: role of proinflammatory cytokinesN Ihendyane, E Sparrelid, B Wretlind, et al.Lancet (London, England)|March 26, 1994
Impact of long-term acyclovir on cytomegalovirus infection and survival after allogeneic bone marrow transplantation. European Acyclovir for CMV Prophylaxis Study GroupH G Prentice, E Gluckman, R L Powles, et al.Transplant Infectious Disease : an Official Journal of the Transplantation Society|June 6, 2009
Targeted monitoring of patients at high risk of post-transplant lymphoproliferative disease by quantitative Epstein-Barr virus polymerase chain reactionH Omar, H Hägglund, A Gustafsson-Jernberg, et al.Journal of Internal Medicine|February 26, 2013
A prospective randomized toxicity study to compare reduced-intensity and myeloablative conditioning in patients with myeloid leukaemia undergoing allogeneic haematopoietic stem cell transplantationO Ringdén, T Erkers, J Aschan, et al.Blood|March 15, 1997
Mutation analysis of IL2RG in human X-linked severe combined immunodeficiencyJ M Puck, A E Pepper, P S Henthorn, et al.Pageof 33